Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2261) 2261
life sciences & biomedicine (2073) 2073
humans (1641) 1641
animals (1469) 1469
stat3 transcription factor - metabolism (1139) 1139
mice (1079) 1079
signal transduction (766) 766
phosphorylation (683) 683
male (615) 615
female (596) 596
oncology (576) 576
cell line, tumor (561) 561
stat3 transcription factor - genetics (541) 541
stat3 (533) 533
stat3 transcription factor (511) 511
stat3 protein (510) 510
immunology (472) 472
cell biology (470) 470
biological and medical sciences (426) 426
biochemistry & molecular biology (424) 424
gene expression (419) 419
cells, cultured (412) 412
stat3 transcription factor - biosynthesis (390) 390
apoptosis (362) 362
signal transduction - drug effects (362) 362
dna-binding proteins - metabolism (361) 361
trans-activators - metabolism (350) 350
cytokines (326) 326
proteins (326) 326
medical sciences (321) 321
mice, inbred c57bl (317) 317
inflammation (304) 304
tumors (301) 301
abridged index medicus (297) 297
rats (295) 295
cell line (286) 286
cancer (277) 277
kinases (266) 266
cell proliferation (259) 259
rodents (235) 235
mice, knockout (224) 224
research (224) 224
stat3 transcription factor - antagonists & inhibitors (217) 217
research article (205) 205
apoptosis - drug effects (204) 204
transfection (198) 198
gene expression regulation, neoplastic (196) 196
analysis (191) 191
science & technology - other topics (188) 188
health aspects (187) 187
multidisciplinary sciences (187) 187
blotting, western (186) 186
middle aged (183) 183
interleukin-6 - biosynthesis (182) 182
interleukin-6 - metabolism (176) 176
rna, messenger - biosynthesis (176) 176
genetic aspects (172) 172
phosphorylation - drug effects (171) 171
mice, inbred balb c (168) 168
cell proliferation - drug effects (165) 165
transcription (165) 165
gene expression regulation (164) 164
stat3 transcription factor - physiology (163) 163
medicine (159) 159
cell growth (157) 157
immunohistochemistry (157) 157
signal transduction - physiology (155) 155
transcription factors (155) 155
physiological aspects (153) 153
adult (151) 151
rna, messenger - genetics (148) 148
interleukin-6 - pharmacology (147) 147
nf-kappa b - metabolism (146) 146
fundamental and applied biological sciences. psychology (144) 144
development and progression (140) 140
disease models, animal (140) 140
medicine, research & experimental (139) 139
research & experimental medicine (139) 139
cytokines - biosynthesis (138) 138
tumor cells, cultured (136) 136
up-regulation (135) 135
aged (134) 134
hematology (132) 132
interleukin-6 - genetics (129) 129
pharmacology & pharmacy (129) 129
interleukin 6 (128) 128
metastasis (127) 127
science (124) 124
genes (123) 123
breast cancer (120) 120
reverse transcriptase polymerase chain reaction (119) 119
signal transduction - genetics (119) 119
care and treatment (116) 116
janus kinase 2 (116) 116
dna-binding proteins - genetics (115) 115
rna, messenger - metabolism (115) 115
neurosciences (114) 114
mice, nude (113) 113
stat1 transcription factor (112) 112
neurosciences & neurology (111) 111
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human Macrophages
by Williams, Lynn and Bradley, Laura and Smith, Alexandra and Foxwell, Brian
The Journal of immunology (1950), ISSN 0022-1767, 01/2004, Volume 172, Issue 1, pp. 567 - 576
Life Sciences & Biomedicine | Immunology | Science & Technology | Protein Binding - genetics | Protein Biosynthesis | Interleukin-6 - antagonists & inhibitors | Humans | Tumor Necrosis Factor-alpha - genetics | Immunoglobulins - genetics | Lipopolysaccharides - antagonists & inhibitors | RNA, Messenger - metabolism | Suppressor of Cytokine Signaling Proteins | Repressor Proteins - antagonists & inhibitors | Antigens, CD - metabolism | Trans-Activators - physiology | Protein Tyrosine Phosphatases - antagonists & inhibitors | RNA, Messenger - biosynthesis | Protein Tyrosine Phosphatases - genetics | Inflammation Mediators - physiology | Glycoproteins - genetics | DNA-Binding Proteins - physiology | Protein Tyrosine Phosphatases - biosynthesis | DNA-Binding Proteins - antagonists & inhibitors | Signal Transduction - genetics | DNA - metabolism | Down-Regulation - genetics | Macrophages - metabolism | Protein Tyrosine Phosphatase, Non-Receptor Type 2 | Repressor Proteins - biosynthesis | Up-Regulation - immunology | Interleukin-10 - antagonists & inhibitors | Lipopolysaccharides - pharmacology | Adenoviruses, Human - genetics | Interleukin-10 - immunology | Tumor Necrosis Factor-alpha - biosynthesis | Phosphorylation | Tissue Inhibitor of Metalloproteinase-1 - biosynthesis | Antigens, CD - biosynthesis | Receptors, Cell Surface | Receptors, IgG - biosynthesis | Receptors, IgG - antagonists & inhibitors | Interleukin-10 - physiology | Signal Transduction - immunology | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Signaling Lymphocytic Activation Molecule Family Member 1 | Receptors, Tumor Necrosis Factor - antagonists & inhibitors | RNA, Messenger - antagonists & inhibitors | Receptors, Tumor Necrosis Factor, Type II | Trans-Activators - genetics | Inflammation Mediators - antagonists & inhibitors | Trans-Activators - biosynthesis | Immunoglobulins - biosynthesis | Macrophages - immunology | Inflammation Mediators - immunology | Receptors, Tumor Necrosis Factor - metabolism | Immune Sera - pharmacology | Proteins - physiology | Cells, Cultured | Glycoproteins - antagonists & inhibitors | Histocompatibility Antigens Class II - biosynthesis | Tissue Inhibitor of Metalloproteinase-1 - antagonists & inhibitors | Transcription Factors - antagonists & inhibitors | Transcription Factors - biosynthesis | Up-Regulation - genetics | DNA-Binding Proteins - genetics | DNA - antagonists & inhibitors | Glycoproteins - biosynthesis | Suppressor of Cytokine Signaling 3 Protein | Down-Regulation - immunology | Interleukin-6 - biosynthesis | Receptors, Tumor Necrosis Factor - biosynthesis | STAT3 Transcription Factor | Trans-Activators - antagonists & inhibitors | Genetic Vectors | DNA-Binding Proteins - biosynthesis | Tumor Necrosis Factor-alpha - antagonists & inhibitors | SOCS-3 protein | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Leptin Activates Human B Cells to Secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 Signaling Pathway
by Agrawal, Sudhanshu and Gollapudi, Sastry and Su, Houfen and Gupta, Sudhir
Journal of clinical immunology, ISSN 0271-9142, 6/2011, Volume 31, Issue 3, pp. 472 - 478
Medical Microbiology | Biomedicine | Immunology | Internal Medicine | Infectious Diseases | activation markers | cytokines | B cells | Autoimmunity | Interleukin-6 - analysis | Janus Kinase 2 - biosynthesis | Mitogen-Activated Protein Kinase 3 - analysis | Humans | p38 Mitogen-Activated Protein Kinases - biosynthesis | p38 Mitogen-Activated Protein Kinases - analysis | Dose-Response Relationship, Drug | Signal Transduction - immunology | Inflammation - metabolism | Mitogen-Activated Protein Kinases - analysis | Mitogen-Activated Protein Kinase 3 - biosynthesis | Mitogen-Activated Protein Kinase 6 - analysis | Leptin - pharmacology | Phosphorylation - drug effects | Interleukin-10 - analysis | B-Lymphocytes - metabolism | Janus Kinase 2 - analysis | Enzyme-Linked Immunosorbent Assay | Lymphocyte Activation | Cells, Cultured | Mitogen-Activated Protein Kinases - biosynthesis | Receptors, Leptin - immunology | STAT3 Transcription Factor - analysis | Inflammation - immunology | Tumor Necrosis Factor-alpha - analysis | STAT3 Transcription Factor - biosynthesis | B-Lymphocytes - drug effects | B-Lymphocytes - immunology | Mitogen-Activated Protein Kinase 6 - biosynthesis | Interleukin-6 - biosynthesis | Interleukin-10 - biosynthesis | Receptors, Leptin - metabolism | Tumor Necrosis Factor-alpha - biosynthesis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Mouse bone marrow-derived mesenchymal stem cells induce macrophage M2 polarization through the nuclear factor-κB and signal transducer and activator of transcription 3 pathways
by Gao, Shuo and Mao, Fei and Zhang, Bin and Zhang, Ling and Zhang, Xu and Wang, Mei and Yan, Yongmin and Yang, Tingting and Zhang, Jie and Zhu, Wei and Qian, Hui and Xu, Wenrong
Experimental biology and medicine (Maywood, N.J.), ISSN 1535-3702, 3/2014, Volume 239, Issue 3, pp. 366 - 375
signaling pathway | macrophage | polarization | inflammation | Mesenchymal stem cells | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Tumor Necrosis Factor-alpha - metabolism | Cell Proliferation | Mannose-Binding Lectins - biosynthesis | Arginase - metabolism | Arginase - biosynthesis | Lectins, C-Type - biosynthesis | Lipopolysaccharides | Benzenesulfonates - pharmacology | Interleukin-10 - metabolism | Receptors, Cell Surface - biosynthesis | STAT3 Transcription Factor - metabolism | Aminosalicylic Acids - pharmacology | Signal Transduction | Cells, Cultured | Mesenchymal Stromal Cells - metabolism | Macrophage Activation | Macrophages - metabolism | Animals | Transcription Factor RelA - metabolism | Interleukin-10 - biosynthesis | Mice | Mice, Inbred BALB C | STAT3 Transcription Factor - antagonists & inhibitors | Tumor Necrosis Factor-alpha - biosynthesis | Mesenchymal Stem Cell Transplantation | Cell Movement | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Egr‐2 transcription factor is required for Blimp‐1‐mediated IL‐10 production in IL‐27‐stimulated CD4+ T cells
by Iwasaki, Yukiko and Fujio, Keishi and Okamura, Tomohisa and Yanai, Atsushi and Sumitomo, Shuji and Shoda, Hirofumi and Tamura, Tomohiko and Yoshida, Hiroki and Charnay, Patrick and Yamamoto, Kazuhiko
European journal of immunology, ISSN 0014-2980, 04/2013, Volume 43, Issue 4, pp. 1063 - 1073
inducible regulatory T (Treg) cells | Egr‐2 | Prdm1 | IL‐10 | IL‐27 | Blimp‐1 | IL-27 | Inducible regulatory T (Treg) cells | Egr-2 | IL-10 | Blimp-1 | Life Sciences & Biomedicine | Immunology | Science & Technology | Promoter Regions, Genetic | Early Growth Response Protein 2 - genetics | Transcriptional Activation | CD4-Positive T-Lymphocytes - metabolism | Interleukin-17 - biosynthesis | Interleukin-17 - pharmacology | Transcription Factors - genetics | Antigens, CD - metabolism | Mice, Knockout | CD4-Positive T-Lymphocytes - immunology | Transcription Factors - metabolism | Animals | Protein Binding | Early Growth Response Protein 2 - metabolism | Interleukin-10 - biosynthesis | Mice | CD4-Positive T-Lymphocytes - drug effects | Interferon-gamma - biosynthesis | STAT3 Transcription Factor - metabolism | Positive Regulatory Domain I-Binding Factor 1 | T cells | Lymphocytes | Immune system | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign
by Poschke, Isabel and Mougiakakos, Dimitrios and Hansson, Johan and Masucci, Giuseppe V and Kiessling, Rolf
Cancer research (Chicago, Ill.), ISSN 0008-5472, 06/2010, Volume 70, Issue 11, pp. 4335 - 4345
Tumors of the skin and soft tissue. Premalignant lesions | Dermatology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Melanoma - blood | Antigens, CD - immunology | Cell Communication - immunology | Immunoglobulins - immunology | Antigens, CD - biosynthesis | Humans | Membrane Glycoproteins - biosynthesis | Middle Aged | Lectins, C-Type - immunology | Oxidative Stress - immunology | Male | Lectins, C-Type - biosynthesis | Cell Adhesion Molecules - immunology | Interleukin-4 Receptor alpha Subunit - biosynthesis | Myeloid Cells - immunology | Calgranulin B - immunology | Aged, 80 and over | Adult | Female | Receptors, Cell Surface - biosynthesis | B7-1 Antigen - biosynthesis | Membrane Glycoproteins - immunology | Immunoglobulins - biosynthesis | Calgranulin B - biosynthesis | B7-1 Antigen - immunology | Cell Adhesion Molecules - biosynthesis | Lymphocyte Activation | Lipopolysaccharide Receptors - immunology | Interleukin-4 Receptor alpha Subunit - immunology | Receptors, Cell Surface - immunology | STAT3 Transcription Factor - biosynthesis | Melanoma - immunology | Interferon-gamma - immunology | T-Lymphocytes - immunology | Aged | HLA-DR Antigens - immunology | STAT3 Transcription Factor - immunology | Interferon-gamma - biosynthesis | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway
by Joung, Youn Hee and Na, Yoon M.I and Yoo, Young Bum and Darvin, Pramod and Sp, Nipin and Kang, Dong Young and Kim, Sang Yoon and Kim, Hong Sup and Choi, Yoon Hee and Lee, Hak Kyo and Park, Kyung D.O and Cho, Byung Wook and Kim, Heui Soo and Park, Jong Hwan and Yang, Young Mok
International journal of oncology, ISSN 1019-6439, 03/2014, Volume 44, Issue 3, pp. 883 - 895
AG490 | Methylsulfonylmethane | Xenograft | Metastasis | Bladder cancer | Janus kinase 2/signal transducer and activator of transcription 3 pathway | Life Sciences & Biomedicine | Oncology | Science & Technology | Cell Survival - drug effects | Vascular Endothelial Growth Factor A - biosynthesis | STAT5 Transcription Factor - biosynthesis | Janus Kinase 2 - biosynthesis | Humans | Dimethyl Sulfoxide - pharmacology | Receptor, IGF Type 1 - biosynthesis | Tyrphostins - pharmacology | Urinary Bladder Neoplasms - drug therapy | Sulfones - pharmacology | STAT3 Transcription Factor - biosynthesis | Xenograft Model Antitumor Assays | Cell Movement - drug effects | RNA, Messenger - biosynthesis | STAT5 Transcription Factor - genetics | Animals | Urinary Bladder Neoplasms - genetics | Signal Transduction - drug effects | Urinary Bladder Neoplasms - pathology | Vascular Endothelial Growth Factor Receptor-2 - biosynthesis | Mice | Gene Expression Regulation, Neoplastic - drug effects | Janus Kinase 2 - antagonists & inhibitors | STAT3 Transcription Factor - genetics
Journal Article
Details down arrow
7. Full Text Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
by Ganji, Purnachandra Nagaraju and Park, Wungki and Wen, Jing and Mahaseth, Hemchandra and Landry, Jerome and Farris, Alton B and Willingham, Field and Sullivan, Patrick S and Proia, David A and El-Hariry, Iman and Taliaferro-Smith, LaTonia and Diaz, Roberto and El-Rayes, Bassel F
Angiogenesis (London), ISSN 0969-6970, 10/2013, Volume 16, Issue 4, pp. 903 - 917
HSP90 | Angiogenesis | Biomedicine | Cancer Research | Oncology | HIF-1α | STAT-3 | Ophthalmology | Cardiology | Biomedicine general | Cell Biology | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Adenocarcinoma - pathology | Humans | Vesicular Transport Proteins - biosynthesis | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Gene Knockdown Techniques | Ribonuclease, Pancreatic - biosynthesis | RNA, Messenger - biosynthesis | Vesicular Transport Proteins - antagonists & inhibitors | Laminin | Platelet-Derived Growth Factor - biosynthesis | Rectal Neoplasms - genetics | STAT3 Transcription Factor - physiology | Rectal Neoplasms - pathology | Ribonuclease, Pancreatic - antagonists & inhibitors | Rectal Neoplasms - drug therapy | STAT3 Transcription Factor - genetics | Transforming Growth Factor beta1 - biosynthesis | Triazoles - therapeutic use | Proteoglycans | Specific Pathogen-Free Organisms | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Down-Regulation | Ribonuclease, Pancreatic - genetics | Angiogenesis Inhibitors - pharmacology | Adenocarcinoma - drug therapy | Chick Embryo | Adenocarcinoma - blood supply | Fibroblast Growth Factor 2 - antagonists & inhibitors | Fibroblast Growth Factor 2 - genetics | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Mice, Nude | Cell Line, Tumor | Human Umbilical Vein Endothelial Cells | Vascular Endothelial Growth Factor A - biosynthesis | Transforming Growth Factor beta1 - antagonists & inhibitors | HSP90 Heat-Shock Proteins - physiology | Gene Expression Regulation, Neoplastic | Hypoxia-Inducible Factor 1, alpha Subunit - antagonists & inhibitors | Platelet-Derived Growth Factor - genetics | HEK293 Cells | Angiogenesis Inhibitors - therapeutic use | Female | Antineoplastic Agents - pharmacology | Hypoxia-Inducible Factor 1, alpha Subunit - physiology | Chorioallantoic Membrane - blood supply | Colorectal Neoplasms - blood supply | Vesicular Transport Proteins - genetics | Fibroblast Growth Factor 2 - biosynthesis | Transforming Growth Factor beta1 - genetics | Triazoles - pharmacology | Xenograft Model Antitumor Assays | Animals | Collagen | Colorectal Neoplasms - pathology | STAT3 Transcription Factor - antagonists & inhibitors | Platelet-Derived Growth Factor - antagonists & inhibitors | Drug Combinations | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Constitutive activation of STAT3 in breast cancer cells: A review
by Banerjee, Kasturi and Resat, Haluk
International journal of cancer, ISSN 0020-7136, 06/2016, Volume 138, Issue 11, pp. 2570 - 2578
transcription factor | breast cancer | tumor growth | regulation | target genes | STAT3 | Life Sciences & Biomedicine | Oncology | Science & Technology | Receptor, Epidermal Growth Factor - genetics | Transcriptional Activation - genetics | Interleukin-6 - genetics | Janus Kinases - genetics | Signal Transduction | Humans | Gene Expression Regulation, Neoplastic | STAT3 Transcription Factor - biosynthesis | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Female | STAT3 Transcription Factor - genetics | Vascular Endothelial Growth Factor Receptor-1 - genetics | Development and progression | Vascular endothelial growth factor | Breast cancer | Signal transduction | Transcription factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma
by Yuan, Ji-hang and Yang, Fu and Wang, Fang and Ma, Jin-zhao and Guo, Ying-jun and Tao, Qi-fei and Liu, Feng and Pan, Wei and Wang, Tian-tian and Zhou, Chuan-chuan and Wang, Shao-bing and Wang, Yu-zhao and Yang, Yuan and Yang, Ning and Zhou, Wei-ping and Yang, Guang-shun and Sun, Shu-han
Cancer cell, ISSN 1535-6108, 05/2014, Volume 25, Issue 5, pp. 666 - 681
Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Neoplasm Transplantation | Up-Regulation | Prognosis | Homeodomain Proteins - metabolism | Humans | Male | MicroRNAs - metabolism | Transplantation, Heterologous | Gene Expression Profiling | Epithelial-Mesenchymal Transition - genetics | RNA, Messenger - metabolism | Zinc Finger E-box Binding Homeobox 2 | Neoplasm Metastasis | Carcinoma, Hepatocellular - genetics | Liver Neoplasms - pathology | Tumor Cells, Cultured | Repressor Proteins - metabolism | STAT3 Transcription Factor - metabolism | Homeodomain Proteins - biosynthesis | Liver Neoplasms - genetics | Neoplasm Invasiveness | Interleukin-11 - genetics | Transcription Factors - biosynthesis | RNA, Long Noncoding - genetics | Transcription Factors - metabolism | Animals | Repressor Proteins - biosynthesis | Mice, Nude | Carcinoma, Hepatocellular - pathology | Mice | Mice, Inbred BALB C | Transforming Growth Factor beta - metabolism | Zinc Finger E-box-Binding Homeobox 1 | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text 2‐Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor‐κB signaling by inhibiting Janus kinase 2 and IκB kinase
by Kuang, Shan and Qi, Chunting and Liu, Jiawei and Sun, Xiaoxiao and Zhang, Qing and Sima, Zhenhua and Liu, Jingli and Li, Wuguo and Yu, Qiang
Cancer science, ISSN 1347-9032, 04/2014, Volume 105, Issue 4, pp. 473 - 480
tumor necrosis factor‐α/nuclear factor‐κB pathway | 2‐Methoxystypandrone | anticancer drug | Janus kinase 2/signal transducer and activator of transcription 3 pathway | natural compound | Anticancer drug | Tumor necrosis factor-α/nuclear factor-κB pathway | Natural compound | 2-Methoxystypandrone | Janus Kinase 2 - biosynthesis | Medicine, Chinese Traditional | Apoptosis - drug effects | Humans | Janus Kinase 2 - genetics | I-kappa B Kinase - biosynthesis | I-kappa B Kinase - genetics | STAT3 Transcription Factor - biosynthesis | NF-kappa B - genetics | Signal Transduction - drug effects | HEK293 Cells | Interleukin-6 - biosynthesis | Naphthoquinones - administration & dosage | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Tumor Necrosis Factor-alpha - biosynthesis | STAT3 Transcription Factor - genetics | Medicinal plants | Membranes | Immunoglobulins | Tumor cells | Stat3 protein | Kinases | Herbal medicine | Proteins | Signal transduction | Cell growth | Cell death | Janus kinase 2 | Janus kinase | Tumor necrosis factor-TNF | Tumorigenesis | Dithiothreitol | Cancer | Glutathione | Tumors | Apoptosis | Index Medicus | signal transducer and activator of transcription 3 pathway | tumor necrosis factor-α | nuclear factor-κB pathway | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Ginkgetin inhibits the growth of DU−145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity
by Jeon, Yoon Jung and Jung, Seung‐Nam and Yun, Jieun and Lee, Chang Woo and Choi, Jiyeon and Lee, Yu‐Jin and Han, Dong Cho and Kwon, Byoung‐Mog
Cancer science, ISSN 1347-9032, 04/2015, Volume 106, Issue 4, pp. 413 - 420
prostate cancer | biflavonoid | STAT3 | Apoptosis | ginkgetin | Biflavonoid | Ginkgetin | Prostate cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Apoptosis - drug effects | Humans | Male | Antineoplastic Agents - therapeutic use | Prostate - pathology | Female | Phosphorylation - drug effects | Interleukin-6 - metabolism | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Inhibitor of Apoptosis Proteins - biosynthesis | Ginkgo biloba - metabolism | HCT116 Cells | Cyclin D1 - biosynthesis | Proto-Oncogene Proteins c-bcl-2 - biosynthesis | STAT3 Transcription Factor - biosynthesis | Xenograft Model Antitumor Assays | Animals | Repressor Proteins - biosynthesis | Mice, Nude | Active Transport, Cell Nucleus - drug effects | Biflavonoids - therapeutic use | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | G1 Phase Cell Cycle Checkpoints - drug effects | STAT3 Transcription Factor - antagonists & inhibitors | Drug Screening Assays, Antitumor | Transcription factors | Cell survival | Transcription | Tumor cells | Therapeutic applications | Stat3 protein | Survivin | Dephosphorylation | Cyclin D1 | Nuclear transport | Herbal medicine | Proteins | Cell growth | Natural products | Cell cycle | Antitumor activity | Protein expression | Localization | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights